Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Intervest Bancshares Q1 Profit Rises - Quick Facts

Intervest Bancshares Corp. (IBCA: Quote), Monday, reported a higher profit for the first quarter.

The New York-based company reported first-quarter net profit available to common stockholders of $2.81 million or $0.13 per share, compared to $1.73 million or $0.08 per share last year.

Net interest and dividend income for the quarter dropped to $9.96 million from $10.35 million in the prior-year quarter.

In the quarter, non-interest income rose to $1.13 million from $323 thousands last year.

Click here to receive FREE breaking news email alerts for INTERVEST BANCSHS and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This apparel maker has doubled its earnings per share in just two years and regularly increasing its annual earnings forecast, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's top-line and bottom-line results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.